Skip to main content

December 2021

 

 

academics

 

Clinical research courses

Morepen gets USFDA Approval for Fexofinadine (Allegra)

Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug Fexofinadine Hydrochloride that is market in India under the popular brand name Allegra, among others and is the block buster drug of the innovator company Sanofi Aventis, France. Fexofinadine is most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever.

Frequently asked questions on SARS-CoV-2 Variant OMICRON

The Union Ministry of Health and Family Welfare has issued answers to Frequently Asked Questions (FAQs) on the new variant of COVID19, classified as Omicron (B.1.1.529) by the WHO on 26th November 2021.

LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that the first patient has been dosed in the Company’s Phase 1/2 clinical trial program for catumaxomab (clinicaltrials.gov: NCT04799847), a monoclonal bispecific antibody being studied for the treatment of Non-Muscle-Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron

Premas Biotech announced that its joint venture Oravax will initiate testing of their oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus through preclinical, in vitro and challenge studies to assess its efficacy for the new mutant strain. Premas Biotech, Oramed Pharmaceuticals, MyMD Pharmaceuticals, and certain other shareholders formed Oravax Medical to bring an oral COVID-19 vaccine to the market.

NIPER amendment bill - NIPER as institute of National Importance to boost pharmaceutical research

National Institute of Pharmaceutical Education and Research (NIPER) amendment bill will boost pharmaceutical research and it will recognised NIPER as institute of National Importance.

Pharmacists Jobs under Health, Medical & Family Welfare Department | 06 posts

Applications are invited from the qualified and eligible candidates with effect from 01-12-2021 to 15-12-2021 (by 05:00 PM) for the recruitment of Paramedical & other Category of Posts sanctioned for the Govt. General Hospital, Nellore on Contract / Outsourcing basis through the District Selection Committee (DSC), SPSR Nellore District.

Post : Pharmacist GR-II

M.Pharm, Life Sciences Job at MPMMCC | Salary RS 30,000 pm

The Tata Memorial Centre (TMC) is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI).

Vacancy for Pharmacists (10 posts) in Government General Hospital

Applications are invited from the eligible candidates for the posts mentioned below on Contract/ Out Sourcing Basis to work in Government General Hospital, Ongole, Prakasam District for the vacancies and newly sanctioned posts in G.O.Ms.No.140 and 141 HM & FW (A1) Dept. Dt.17.11.2021.

Post : Pharmacist GR-II

Walk in interview for Pharmacist at Homi Bhabha Cancer Hospital and Research Centre

The Tata Memorial Centre is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India. TMC is affiliated to Homi Bhabha National Institute (HBNI).

Post : Pharmacist

Opportunity for M.Pharm, M.Sc as Clinical Research Associate at Teva Pharmaceutical

Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we've built a promising pipeline centered around our core therapeutic areas.